No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF

Abstract

BackgroundCerebrospinal fluid (CSF) biomarkers have gained increasing importance in the diagnostic work-up of Alzheimer’s disease (AD). The core CSF biomarkers related to AD pathology (Aβ42, t-tau and p-tau) are currently used in CSF diagnostics, while candidate markers of amyloid metabolism (Aβ38, Aβ40, sAPPα, sAPPβ), synaptic loss (neurogranin), neuroinflammation (YKL-40), neuronal damage (VILIP-1) and genetic risk (apolipoprotein E) are undergoing evaluation. Diurnal fluctuation in the concentration of CSF biomarkers has been reported and may represent a preanalytical confounding factor in the laboratory diagnosis of AD. The aim of the present study was to investigate the diurnal variability of classical and candidate CSF biomarkers in a cohort of neurosurgical patients carrying a CSF drainage.MethodSamples were collected from a cohort of 13 neurosurgical patients from either ventricular (n = 6) or lumbar (n = 7) CSF drainage at six time points during the day, 1–7 days following the neurosurgical intervention. Concentrations of the core biomarkers were determined by immunoassays.ResultsAlthough absolute values largely varied among subjects, none of the biomarkers showed significant diurnal variation. Site of drainage (lumbar vs. ventricular) did not influence this result. The different immunoassays used for tau and Aβ markers provided similar results.ConclusionTime of day at CSF collection does not ultimately affect the concentration levels of classical and candidate AD biomarkers. Similar trends were found when using different immunoassays, thus corroborating the consistency of the data.Electronic supplementary materialThe online version of this article (doi:10.1186/s13024-016-0130-3) contains supplementary material, which is available to authorized users.

Serum tau concentration after diving – an observational pilot study

“…There was a difference between the time of day when samples 1 and 2 were taken. Studies show no diurnal variation in CSF tau levels, [23][24][25] making it improbable that they should fluctuate in the blood significantly during the day. Nevertheless, a representative control group could have ensured that no confounding factors, such as diurnal variation, were responsible for changes in serum tau.…”

“…23 Another study on neurosurgical patients showed no diurnal variation in CSF tau levels. 24 Likewise, there was no significant diurnal variation in CSF tau levels among older patients with idiopathic normal pressure hydrocephalus or pseudotumor cerebri, when studied through sequential CSF sampling. 25 Most likely serum tau levels reflect those in CSF.…”

Tau or neurofilament light—Which is the more suitable biomarker for Huntington’s disease?

“…Some trends suggested herein may prove significant in larger materials. Timing of meals and the time of day for sampling varied, but this is not likely to influence the results, at least regarding tau [ 30 ]. To avoid such limitations, we would like to recommend the HD Clarity project which is a new initiative for a multicenter collection of HD CSF which aims to enroll a large number of participants allowing statistical power for multiple analyses while offering a standardized protocol for CSF collection.…”

The “glymphatic” mechanism for solute clearance in Alzheimer's disease: game changer or unproven speculation?

“…In addition, sleep deprivation increases amyloid plaque deposition in mice (75). A circadian pattern in the CSF concentration of Aβ has been identified in which Aβ concentration is increased during wakefulness (76), although the magnitude of circadian variation is small and has not been consistently seen (77). The large transfer of fluid from the intracellular to extracellular compartment on wake‐to‐sleep transition, as observed by Xie et al (28), requires a large transfer of solutes (mainly NaCl) into the ECS, and it has been questioned how this can occur (8).…”